Efloxate - Misplaced Pages

Chemical compound

This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Efloxate" – news · newspapers · books · scholar · JSTOR (February 2022) (Learn how and when to remove this message)

Pharmaceutical compound

Efloxate
Clinical data

ATC code	C01DX13 (WHO)
Identifiers
IUPAC name ethyl 2-acetate
CAS Number	119-41-5
PubChem CID	8395
ChemSpider	8089
UNII	CZU6V3902K
ChEMBL	ChEMBL1349073
CompTox Dashboard (EPA)	DTXSID3048736
ECHA InfoCard	100.003.929
Chemical and physical data
Formula	C₁₉H₁₆O₅
Molar mass	324.332 g·mol
3D model (JSmol)	Interactive image
SMILES CCOC(=O)COc1ccc2c(=O)cc(oc2c1)c3ccccc3
InChI InChI=1S/C19H16O5/c1-2-22-19(21)12-23-14-8-9-15-16(20)11-17(24-18(15)10-14)13-6-4-3-5-7-13/h3-11H,2,12H2,1H3 Key:ZVXBAHLOGZCFTP-UHFFFAOYSA-N
(verify)

Efloxate is a vasodilator.

References

Tomasi AM, Masoni A (August 1977). "". La Clinica Terapeutica (in Italian). 82 (3): 227–41. PMID 334448.

v t e Vasodilators used in cardiac diseases (C01D)
Nitrovasodilators	Nitroglycerin # Isosorbide dinitrate # Isosorbide mononitrate Itramin tosilate Linsidomine Molsidomine Nicorandil Pentaerythritol tetranitrate Propatylnitrate Tenitramine Trolnitrate
Quinolone vasodilators	Flosequinan
Others	Benziodarone Carbocromen Cinepazet Cloridarol Dilazep Efloxate Etafenone Gapicomine Heptaminol Hexobendine Imolamine Levosimendan Nesiritide Nicorandil Oxyfedrine Pimobendan Prenylamine Serelaxin Trapidil Vericiguat
WHO-EM Withdrawn from market Clinical trials: Phase III Never to phase III

This drug article relating to the cardiovascular system is a stub. You can help Misplaced Pages by expanding it.